New drugs bring hope to ALS patients

Recently, attention has again been focused on ALS. The fatal neurological disease has long been one of the biggest medical mysteries. Today, the knowledge surrounding ALS has vastly improved, largely thanks to increased attention as well as increased research funding. The investments have led to a new drug receiving conditional FDA approval this autumn, which has raised the hopes of ALS patients.

Read the article at biostock.se:

https://www.biostock.se/en/2022/12/new-drugs-bring-hope-to-als-patients/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/